Monsanto Company (MON) Stake Boosted by Temasek Holdings Private Ltd
Temasek Holdings Private Ltd grew its holdings in Monsanto Company (NYSE:MON) by 99.1% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 429,184 shares of the basic materials company’s stock after purchasing an additional 213,650 shares during the period. Temasek Holdings Private Ltd owned approximately 0.10% of Monsanto worth $51,425,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also modified their holdings of MON. OZ Management LP grew its position in Monsanto by 5.4% during the 3rd quarter. OZ Management LP now owns 2,162,165 shares of the basic materials company’s stock worth $259,070,000 after acquiring an additional 110,919 shares during the last quarter. B. Riley Financial Inc. bought a new stake in Monsanto during the 3rd quarter worth $846,000. Sand Grove Capital Management LLP grew its position in Monsanto by 11.3% during the 3rd quarter. Sand Grove Capital Management LLP now owns 1,003,320 shares of the basic materials company’s stock worth $119,736,000 after acquiring an additional 101,477 shares during the last quarter. Nippon Life Global Investors Americas Inc. grew its position in Monsanto by 14.7% during the 3rd quarter. Nippon Life Global Investors Americas Inc. now owns 76,970 shares of the basic materials company’s stock worth $9,224,000 after acquiring an additional 9,870 shares during the last quarter. Finally, Sompo Japan Nipponkoa Asset Management CO. LTD. bought a new stake in Monsanto during the 3rd quarter worth $9,472,000. Institutional investors own 75.70% of the company’s stock.
A number of equities research analysts recently weighed in on MON shares. Piper Jaffray Companies set a $128.00 price objective on Monsanto and gave the stock a “buy” rating in a research report on Friday, August 11th. UBS lowered Monsanto from a “buy” rating to a “neutral” rating and set a $128.00 price target on the stock. in a research report on Friday, August 18th. BidaskClub upgraded Monsanto from a “sell” rating to a “hold” rating in a research report on Saturday, August 19th. Zacks Investment Research upgraded Monsanto from a “hold” rating to a “buy” rating and set a $131.00 price target on the stock in a research report on Tuesday, August 29th. Finally, BMO Capital Markets reiterated a “buy” rating and issued a $128.00 price target on shares of Monsanto in a research report on Friday, September 1st. Eleven investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and an average price target of $124.61.
Monsanto Company (MON) traded up $0.03 during midday trading on Wednesday, hitting $118.29. The company’s stock had a trading volume of 621,897 shares, compared to its average volume of 1,962,239. Monsanto Company has a 1 year low of $104.08 and a 1 year high of $122.79. The company has a market cap of $52,212.13, a price-to-earnings ratio of 21.45, a PEG ratio of 1.71 and a beta of 1.04. The company has a debt-to-equity ratio of 1.12, a current ratio of 1.35 and a quick ratio of 0.83.
Monsanto (NYSE:MON) last announced its quarterly earnings data on Wednesday, October 4th. The basic materials company reported $0.20 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.41) by $0.61. The company had revenue of $2.69 billion for the quarter, compared to the consensus estimate of $2.51 billion. Monsanto had a return on equity of 42.40% and a net margin of 15.44%. The firm’s revenue was up 4.8% compared to the same quarter last year. During the same period in the previous year, the business earned $0.07 EPS. analysts forecast that Monsanto Company will post 5.74 earnings per share for the current year.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 26th. Stockholders of record on Friday, January 5th will be paid a $0.54 dividend. This represents a $2.16 dividend on an annualized basis and a dividend yield of 1.83%. The ex-dividend date of this dividend is Thursday, January 4th. Monsanto’s dividend payout ratio is 42.27%.
In other news, EVP Steven Mizell sold 11,526 shares of the business’s stock in a transaction dated Monday, October 9th. The stock was sold at an average price of $119.70, for a total value of $1,379,662.20. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, CFO Pierre Courduroux sold 4,320 shares of the business’s stock in a transaction dated Thursday, October 19th. The shares were sold at an average price of $122.00, for a total value of $527,040.00. Following the completion of the transaction, the chief financial officer now directly owns 48,388 shares in the company, valued at $5,903,336. The disclosure for this sale can be found here. Insiders sold a total of 49,236 shares of company stock worth $5,931,934 over the last three months. 0.79% of the stock is owned by company insiders.
COPYRIGHT VIOLATION WARNING: This news story was originally reported by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are accessing this news story on another publication, it was illegally copied and reposted in violation of US and international trademark and copyright law. The legal version of this news story can be accessed at https://theolympiareport.com/2017/12/06/monsanto-company-mon-stake-boosted-by-temasek-holdings-private-ltd.html.
Monsanto Company Profile
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related companies with Analyst Ratings Network's FREE daily email newsletter.